In conclusion, our study reveals the potential role of IRF5 derived from M1‐like macrophage exosomes in lung cancer treatment through the upregulation of HLA‐E expression, thus providing a novel theoretical foundation for future immunotherapy strategies. The gene discussed is HLA-E; the disease is lung carcinoma.